Displaying items by tag: Health

The Government is expanding its ‘Advice and Guidance’ scheme to help GPs provide quicker, community-based care and reduce hospital waiting lists. With £80 million in new funding, the goal is to assist two million patients, avoiding unnecessary referrals and offering more convenient treatment for conditions like menopause symptoms, ear infections, and irritable bowel syndrome. The scheme enables GPs to consult directly with hospital specialists before formally referring patients, allowing many to be treated locally. Health minister Karin Smyth says the initiative is part of 'rewiring the NHS’, reducing strain on hospital services while saving patients time. GP surgeries can also claim fees for each use of the system. While the scheme has been welcomed as a step in the right direction, health charities stress the importance of clear communication and patient choice. Medical groups say this must be paired with greater investment and long-term reform to truly safeguard the future of family doctor services.

The Safe Motherhood Programme, which has drastically reduced maternal and neonatal mortality in Nepal, is at risk due to severe funding shortages. Rs 380 million (£2 million) is urgently needed to reimburse hospitals and continue essential services. An additional Rs 600 million (£3.3 million) will be needed this fiscal year to sustain operations. Launched two decades ago, the programme offers free delivery services, antenatal checkup incentives, and transportation allowances. It helped raise institutional deliveries from 18% to 80% and cut the maternal mortality rate from 539 per 100,000 live births in 1996 to 239 by 2016. However, nearly 130 maternal deaths have already occurred in the current fiscal year. The WHO has warned that progress toward the goal of reducing maternal mortality to 75 per 100,000 by 2030 could stall without immediate investment. The report stresses that broader efforts, like ensuring girls’ education, improving family planning, and tackling health inequalities, are crucial to safeguarding maternal and newborn lives.

A new at-home saliva test assessing genetic risk has shown greater accuracy than the current PSA blood test in detecting prostate cancer, according to a major UK study. The spit test, which evaluates 130 genetic variants to calculate a polygenic risk score (PRS), was found to be more effective at identifying aggressive prostate cancers than traditional PSA testing. Led by Prof Ros Eeles at the Institute of Cancer Research in London, the study demonstrated that 40% of high-risk men flagged by the test were diagnosed with cancer, compared to 25% diagnosed through PSA testing. Moreover, the saliva test detected a higher proportion of aggressive cancers. This non-invasive, inexpensive tool could improve early diagnosis and reduce unnecessary treatments linked to false positives from PSA tests. Researchers are also developing updated versions of the test tailored for men of Asian and African heritage. While further research is needed to confirm long-term outcomes, experts hope the PRS test could soon revolutionise screening for men most at risk, offering better protection and peace of mind.

Experts warn the UK is wasting billions annually by failing to diagnose and care for people with bipolar disorder. An estimated one million people live with the condition, yet many are misdiagnosed, undertreated, or entirely overlooked. Patients have undergone years of suffering, misdiagnosis, and crisis before they finally received proper care. New data put the cost of bipolar-related care and economic loss at £9.6 billion a year. Yet experts say that with early diagnosis, consistent medication, and specialist care programmes, hospital admissions could be dramatically reduced and lives transformed. One model in South London has seen readmission rates drop by 80%. Despite the evidence, care remains patchy and specialist services limited. Campaigners and clinicians are urging a national care pathway and greater access to psychiatrists to stop the cycle of crisis and neglect, calling the current situation both a human tragedy and a financial folly.

Assisted dying may not be available in England and Wales until at least 2029 after MPs approved extending the rollout period from two to four years. The delay was proposed by Kim Leadbeater, the Labour MP behind the bill, who emphasised the importance of thoroughness over speed. Although she acknowledged supporters' disappointment, she believed a well-constructed law was paramount; the bill would return to the Commons in a 'safer, fairer, and more workable' form. Tom Gordon, a Liberal Democrat MP, warned the delay risked pushing the bill beyond the next general election, potentially leading to its abandonment. Critics argue the delay prolongs unnecessary suffering for terminally ill patients, while opponents worry it may pressure vulnerable individuals into ending their lives. Ms Leadbeater removed a safeguard requiring High Court scrutiny, proposing a panel including a lawyer, psychiatrist, and social worker instead. The bill initially passed with 330 MPs in favour and 275 against. See

The UN AIDS agency has warned of a potential global health crisis, with projections of 2,000 new HIV infections daily and up to 6.3 million AIDS-related deaths over the next four years, if US foreign aid remains frozen. The halt, ordered by Donald Trump under his ‘America First’ policy, has disrupted critical healthcare services. Although the State Department has said that life-saving programmes will continue, UNAIDS reports that many clinics have already closed and thousands of health workers have been laid off. There are fears that this sudden collapse in funding will reverse decades of progress in combating HIV/AIDS, especially in vulnerable regions. In 2023 alone, there were 600,000 AIDS-related deaths globally. UNAIDS, which relies on the US for 35% of its core funding, says unless aid resumes or is replaced by another source, the world could face a devastating resurgence of the epidemic, echoing the crises seen in the 1990s and early 2000s. Trump’s team members say they have saved US taxpayers tens of billions of dollars by cancelling contracts, firing workers and rooting out fraud and waste, but they have offered little evidence to support that assertion.

In the Gambia, many people enjoy taba, a powdered tobacco product, by smoking or snuffing or chewing it. However, it is increasingly being mixed with potent chemicals and used intravaginally by women seeking sexual enhancement or relief from health issues. Though it is not illegal, health professionals warn of serious risks, including infections, tissue damage, and even cancer. Stories of extreme pain, bleeding, and near-death experiences are surfacing, yet some users and sellers deny its dangers. While some women claim medicinal benefits, many suffer silently due to stigma and fear. The ministry of health and women's rights groups are actively campaigning to raise awareness, with public warnings from medical professionals and  videos from government officials. Doctors say taba’s harmful effects could include long-term reproductive damage and increased risk of sexually transmitted infections.

Keir Starmer has announced plans to abolish NHS England, aiming to cut bureaucracy and redirect funds to frontline healthcare. Calling it an ‘arms-length body’, he argued that scrapping it would eliminate duplication, saving money for nurses and patient care. Health secretary Wes Streeting acknowledged that up to 10,000 jobs could be cut, but said reform was necessary to reduce inefficiency. NHS England, established in 2013, oversees daily NHS operations with a £168 million budget. Last month, its chief executive Amanda Pritchard stepped down, reflecting mounting pressures. Starmer’s broader government efficiency plan includes AI-driven reforms to streamline state functions, aiming to save £45 billion, and to cut compliance costs for businesses by 25%. He criticised the state as overstretched and ineffective, promising to reduce regulatory burdens. Streeting called the move the ‘final nail in the coffin’ of the ‘disastrous’ 2012 NHS reorganisation, pledging to empower healthcare workers and shorten waiting times.

A medical milestone has been achieved: the first patient implanted with a durable artificial heart has been discharged from hospital. BiVACOR, a titanium mechanical blood pump, was successfully implanted in a man suffering from severe heart failure. Performed at St Vincent’s Hospital in Sydney, the six-hour surgery marked a breakthrough in cardiac care. Designed to function indefinitely, BiVACOR operates using magnets to eliminate mechanical wear. Queensland-born inventor Daniel Timms spent years developing the device, inspired by childhood experiences working with his father, who later died of heart failure. The patient, previously too weak to walk, lived with the device for over 100 days before receiving a human heart transplant. Doctors anticipate BiVACOR could eventually replace the need for human donors. With more implants planned, this innovation offers new hope to those awaiting transplants.

Scientists at the University of Cambridge have discovered how aspirin may help prevent cancer from spreading. Their research suggests that the drug enhances the immune system’s ability to fight cancer by stopping platelets from suppressing T-cells, the body’s natural defence against cancer. When cancer cells break away from a tumour, they try to spread elsewhere in the body - a process called metastasis, which causes most cancer deaths. Normally, T-cells can destroy these wandering cancer cells. However, platelets, which help stop bleeding, interfere with T-cell activity, allowing cancer to spread. Aspirin appears to disrupt this process, restoring the immune system’s ability to attack cancer. While these findings are promising, scientists caution against self-medicating with aspirin, as it carries risks such as internal bleeding. Clinical trials are ongoing to determine which patients may benefit. Researchers hope this breakthrough will eventually lead to safer, more targeted treatments that mimic aspirin’s benefits without its risks.